Adjusted Comparison of Daratumumab Monotherapy Versus Real-World Historical Control Data From The Czech Republic in Heavily Pre-Treated and Highly Refractory Multiple Myeloma Patients
Abstract
Authors
J Diels X Gatopoulou H Besson S Vesela R Hájek J Jarkovsky T Ito